19.11.2007 13:00:00

Cognex In-Sight Vision Sensors Selected by NEXUS Biosystems

Cognex Corporation (NASDAQ: CGNX) announced today that NEXUS Biosystems, a developer of automation systems for the pharmaceutical and biotech industry, will integrate Cognex’s In-Sight® 5603 vision sensor into its Universal Store® system. The Universal Store is an automated system used in the biotech and pharmaceutical industries for managing hundreds of thousands to millions of laboratory samples and compounds. The In-Sight vision sensors will be used to read data matrix codes etched on each sample vial. The codes enable the Universal Store system to automatically store and then retrieve individual vials when those samples are required for testing. "We selected In-Sight for this application because speed and accuracy are critical,” said John Lillig, President and CEO of NEXUS Biosystems. "In-Sight can read an entire tray of up to 96 vials at once with 100 percent accuracy, which enables us to facilitate quick identification, storage and retrieval of large quantities of samples.” "This is a significant win for Cognex for two important reasons,” said Dr. Robert J. Shillman, Chairman and CEO of Cognex. "First, because of its size.... we expect bookings to total near the mid-six figures...and second, because the application represents an entirely new and very promising market for Cognex vision.” Cognex In-Sight 5600 series vision sensors are the fastest on the market, helping manufacturers achieve significant improvements in productivity, quality and cost reduction. The 5603 model adds the highest resolution (1600 X 1200 pixels) available in the In-Sight product line, and offers a full library of vision tools for guidance, inspection, gauging, as well as identification. About NEXUS Biosystems, Inc. NEXUS Biosystems, a privately held company based in Poway, California, USA, has since 1996 been a developer and provider of enabling technologies and automation systems for pharmaceutical, biotech, agrochemical and academic research institutions worldwide. Current products include the Universal Store® and Universal LabStore® family of next generation sample storage and retrieval systems, the Crystal Farm® line of protein crystallization systems, and the IRORI® line of chemical synthesis technologies and services. More information is available at www.nexusbio.com. About Cognex Cognex Corporation designs, develops, manufactures and markets machine vision sensors and systems, or devices that can "see." Cognex vision sensors are used in factories around the world to automate the manufacture of a wide range of items and to assure their quality. Cognex is the world's leader in the machine vision industry, having shipped more than 400,000 machine vision systems, representing over $2 billion in cumulative revenue, since the company's founding in 1981. In addition it its corporate headquarters in Natick, Massachusetts, Cognex also has regional offices and distributors located throughout North America, Japan, Europe, Asia and Latin America. Visit Cognex on-line at http://www.cognex.com.
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Cognex Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Cognex Corp. 38,31 -0,67% Cognex Corp.

Indizes in diesem Artikel

NASDAQ Comp. 19 954,30 -0,50%
S&P 600 SmallCap 935,46 -0,94%